Glucagon + Insulin
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Type 1 Diabetes Mellitus With Hypoglycemia
Conditions
Type 1 Diabetes Mellitus With Hypoglycemia
Trial Timeline
Sep 15, 2020 → Jan 10, 2021
NCT ID
NCT04712266About Glucagon + Insulin
Glucagon + Insulin is a phase 1 stage product being developed by Abvance Therapeutics for Type 1 Diabetes Mellitus With Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT04712266. Target conditions include Type 1 Diabetes Mellitus With Hypoglycemia.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04712266 | Phase 1 | Completed |
Competing Products
20 competing products in Type 1 Diabetes Mellitus With Hypoglycemia